Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Cartesian Therapeutics Inc (RNAC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cartesian Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
18.260 +0.350    +1.95%
22/04 - Closed. Currency in USD ( Disclaimer )
After Hours
18.260
-0.000
-0.000%
16:18:42 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 81,807
  • Bid/Ask: 10.050 / 22.000
  • Day's Range: 16.985 - 18.980
Cartesian Therapeutics 18.260 +0.350 +1.95%

NASDAQ:RNAC Financials

 
A brief overview of the NASDAQ:RNAC financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Cartesian Therapeutics Inc over time.

Cartesian Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 219.71 million compared to net income of USD 35.38 million a year ago. Basic loss per share from continuing operations was USD 1.66 compared to basic earnings per share from continuing operations of USD 0.24 a year ago. Diluted loss per share from continuing operations was USD 1.66 compared to diluted earnings per share from continuing operations of USD 0.1 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

RNAC Income Statement

Gross margin TTM -176.26%
Operating margin TTM -332.32%
Net Profit margin TTM -844.91%
Return on Investment TTM 0%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 26 6.55 5.25 5.94
Gross Profit -38.87 -6.45 -12.53 -12.69
Operating Income -78.16 -13.06 -18.64 -18.38
Net Income -211.95 -9 -11.39 -21.66

RNAC Balance Sheet

Quick Ratio MRQ 1.26
Current Ratio MRQ 1.33
LT Debt to Equity MRQ 0%
Total Debt to Equity MRQ -2.49%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 305.05 106.03 139.51 155.69
Total Liabilities 444.68 45.7 74.06 81.11
Total Equity -139.63 60.33 65.45 74.58

RNAC Cash Flow Statement

Cash Flow/Share TTM -9.89
Revenue/Share TTM 5.03
Operating Cash Flow  -65.47%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -44.66 -9.22 -9.9 -8.76
Cash From Investing Activities 34.66 0 -0.012 28.12
Cash From Financing Activities -14.57 -24.79 -2.59 0.149
Net Change in Cash -24.62 -34.02 -12.52 19.49
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RNAC Comments

Write your thoughts about Cartesian Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bill Kuiphoff
Bill Kuiphoff Mar 12, 2024 1:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ELTP 👍
James Lowe
JLowe Aug 04, 2022 1:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I am not going to tell you this is going to USD3.00
James Lowe
JLowe Jul 07, 2022 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy now!!!
James Lowe
JLowe Jun 01, 2022 6:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy!!!
Olga Stadler
Olga Stadler Jun 01, 2022 6:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why?
Financial Advisors
Financial Advisors Dec 15, 2021 2:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i can tell you Anne .
Anne Rusnes
Anne Rusnes Jul 23, 2021 6:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
someone Who can tell me more about this stock?
Erez Tubul
Erez Tubul Jan 27, 2021 5:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy before january 29
Rafael Restrepo
Rafael Restrepo Oct 26, 2020 10:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any news?
MoneyManager MoneyManager
Money2Manage4U Oct 26, 2020 10:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i am an experienced advisor if you want some advises please let me know.   0 0 3 5 9 8 7 9 2 7 7 7 6 6
MoneyManager MoneyManager
Money2Manage4U Oct 26, 2020 10:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Selecta Biosciences Peter G Traber  Buy 40,000 shares @ $3.24 $129,600.00 12/14/2020
Andrew silvagni
Andrew silvagni Jun 23, 2020 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don't wait too long. It's just being shorted and should bounce right back up through the night while all the bags get bought.
Colin Edmonston
Colin Edmonston Jun 23, 2020 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How can you tell if it's being shorted? Trying to continue learning everything I can about it.
Tameem Sanjar
Tameem Sanjar Jun 23, 2020 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Colin Edmonston  https://www.tradingview.com/markets/stocks-usa/market-movers-oversold/
Andrew silvagni
Andrew silvagni Jun 23, 2020 2:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sorrento therapeutics is making me big $!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email